autologous cd34+ cells transduced withpsrs11.efs.il2rg.pre
Cell therapyexperimental
Clinical trial activity
8 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 1996 (NCT00058773)
Timeline
Indications
Studied for
- Burkitt Lymphoma · Phase 2
- Head and Neck Neoplasms · Phase 1
- Hodgkin Disease · Phase 1
- Lupus Erythematosus, Systemic · Phase 1/Phase 2
- Lymphoma, Non-Hodgkin · Phase 1
- Multiple Sclerosis, Chronic Progressive · Phase 1
- Nasopharyngeal Carcinoma · Phase 2
- Neoplasms · Phase 2
- X-Linked Combined Immunodeficiency Diseases · Phase 1/Phase 2
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous cd34+ cells transduced withpsrs11.efs.il2rg.pre
- autologous ebv specific ctl
- ebv specific cytotoxic t-lymphocytes
- ebv-specific cytotoxic t lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06391814 | N/A | Jan 16, 2024 | Ciusss de L'Est de l'Île de Montréal |
| NCT03988582 | Phase 2 | Jun 11, 2019 | Memorial Sloan-Kettering Cancer Center |
| NCT03283826 | Phase 1 | Oct 19, 2017 | Atara Biotherapeutics |
| NCT02677688 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2016 | University of Nantes |
| NCT01175239 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2011 | University of London |
| NCT00953420 | Phase 2 | Nov 1, 2009 | Baylor University, Methodist Cancer Center, Houston, Texas, University of Texas at Houston |
| NCT00609219 | Phase 1 | Aug 1, 2001 | Baylor University, Methodist Cancer Center, Houston, Texas |
| NCT00058773 | Phase 1 | Jan 1, 1996 | Baylor University, Methodist Cancer Center, Houston, Texas |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 3 | 3 | 2 | 1996 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 3 | 0 | 2 | 1996 |
| Atara Biotherapeutics | For profit | 1 | 1 | 1 | 2017 |
| Ciusss de L'Est de l'Île de Montréal | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Nantes | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2009 |
8 organizations
Page 1 / 1